The Elias Tillandz prize 2024 was awarded to an outstanding research article which offers a possible explanation as to why higher breast density and older age increase the risk of breast cancer. The Prize was awarded to the researchers at the BioCity symposium on Thursday, 29 August 2024.
Physicist Stefan Hell, who started his research at the University of Turku in the 1990s, was awarded the Nobel Prize in Chemistry in autumn 2014. The 10th anniversary of the prize will be celebrated on 4 September with a portrait unveiling at 12-14 in Alhopuro lecture hall and a science and art event open to the public at 14-20 at Visitor Centre Joki.
Heidi Furu, MD, has been elected Professor of Practice in Occupational Health and Occupational Medicine at the University of Turku. She is a distinguished researcher, occupational health physician and teacher of occupational health physicians. The main role of the Professor of Practice is to promote research in occupational health and medicine and to contribute research knowledge to the societal debate.
The University of Turku's multidisciplinary mentoring programme supports students' transition to working life and maintains interaction with the university and its educators.
Registration to BioCity Symposium is open until 16 August 2024. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged with title Unleashing the Power of Metabolism
A large international study conducted at the University of Turku in Finland found that most adolescents do not seek professional help even when they have a high level of mental health problems. This unmet need was prevalent across all eight Asian and European countries involved in this study but especially in lower-income countries.
Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body. Finnish cancer researchers discovered a mechanism that wakes up these dormant breast cancer cells and demonstrated that preventing the mechanism can significantly improve treatment outcomes in experimental models.